Blood Test Algorithm Cuts Unneeded Amyloid PET Scans in Alzheimer's Trial Screening
USC researchers say a plasma-based screening tool reduced scans that ended in ineligibility from 71% to 31% during recruitment for the AHEAD 3-45 trial.
Nov 1, 2026 · 3 min read
47 views